As Aspen Aerogels (ASPN) Market Value Rose, Harvey Partners Has Increased Position by $369,728; Cue Financial Group Boosted Position in Idexx Labs (IDXX) as Share Value Rose

January 12, 2018 - By Michael Collier

Jeffrey Moskowitz increased its stake in Aspen Aerogels Inc (ASPN) by 32.24% based on its latest 2017Q3 regulatory filing with the SEC. Harvey Partners Llc bought 92,432 shares as the company’s stock rose 0.23% with the market. The hedge fund run by Jeffrey Moskowitz held 379,100 shares of the consumer services company at the end of 2017Q3, valued at $1.65 million, up from 286,668 at the end of the previous reported quarter. Harvey Partners Llc who had been investing in Aspen Aerogels Inc for a number of months, seems to be bullish on the $119.37 million market cap company. The stock increased 1.00% or $0.05 during the last trading session, reaching $5.05. About 14,424 shares traded. Aspen Aerogels, Inc. (NYSE:ASPN) has risen 3.77% since January 12, 2017 and is uptrending. It has underperformed by 12.93% the S&P500.

Cue Financial Group Inc increased its stake in Idexx Labs Inc (IDXX) by 125.87% based on its latest 2017Q3 regulatory filing with the SEC. Cue Financial Group Inc bought 3,090 shares as the company’s stock rose 13.64% with the market. The institutional investor held 5,545 shares of the health care company at the end of 2017Q3, valued at $862,000, up from 2,455 at the end of the previous reported quarter. Cue Financial Group Inc who had been investing in Idexx Labs Inc for a number of months, seems to be bullish on the $14.96B market cap company. The stock increased 3.23% or $5.37 during the last trading session, reaching $171.51. About 526,284 shares traded or 4.44% up from the average. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 83.30% since January 12, 2017 and is uptrending. It has outperformed by 66.60% the S&P500.

Among 8 analysts covering Aspen Aerogels (NYSE:ASPN), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Aspen Aerogels had 14 analyst reports since August 7, 2015 according to SRatingsIntel. On Monday, November 14 the stock rating was downgraded by Citigroup to “Neutral”. The rating was maintained by Needham on Friday, November 3 with “Buy”. JP Morgan maintained Aspen Aerogels, Inc. (NYSE:ASPN) rating on Friday, August 5. JP Morgan has “Overweight” rating and $7 target. The rating was maintained by Canaccord Genuity on Thursday, July 27 with “Buy”. The firm has “Overweight” rating by KeyBanc Capital Markets given on Thursday, April 14. Needham initiated Aspen Aerogels, Inc. (NYSE:ASPN) rating on Monday, August 10. Needham has “Buy” rating and $9.5 target. The firm earned “Neutral” rating on Friday, November 4 by JP Morgan. Craig Hallum initiated the stock with “Buy” rating in Tuesday, September 20 report. As per Friday, February 24, the company rating was maintained by Needham. The stock of Aspen Aerogels, Inc. (NYSE:ASPN) earned “Neutral” rating by Seaport Global Securities on Friday, November 4.

Investors sentiment increased to 2 in 2017 Q3. Its up 1.00, from 1 in 2017Q2. It increased, as 5 investors sold ASPN shares while 8 reduced holdings. 11 funds opened positions while 15 raised stakes. 25.64 million shares or 5.17% less from 27.04 million shares in 2017Q2 were reported. Royal Financial Bank Of Canada has invested 0% in Aspen Aerogels, Inc. (NYSE:ASPN). United Services Automobile Association invested in 173,186 shares. Bard Associates Incorporated reported 0% in Aspen Aerogels, Inc. (NYSE:ASPN). New York-based State Common Retirement Fund has invested 0% in Aspen Aerogels, Inc. (NYSE:ASPN). Port Solutions invested 0% of its portfolio in Aspen Aerogels, Inc. (NYSE:ASPN). Financial Bank Of America De reported 5,442 shares. Ameriprise Finance invested in 0% or 986,024 shares. Heartland Advsr reported 927,066 shares or 0.26% of all its holdings. 5,300 were reported by Nationwide Fund Advsr. Cetera Advisor Networks Ltd Liability Company stated it has 0% in Aspen Aerogels, Inc. (NYSE:ASPN). 418,663 are held by Perritt Cap. New York-based Renaissance Limited Liability Company has invested 0% in Aspen Aerogels, Inc. (NYSE:ASPN). Jacobs Levy Equity holds 31,400 shares or 0% of its portfolio. Needham Inv Management Limited Liability Company invested in 0.48% or 435,000 shares. Harvey Partners Llc has invested 1.89% in Aspen Aerogels, Inc. (NYSE:ASPN).

Since August 8, 2017, it had 0 buys, and 5 sales for $17.16 million activity. AYERS JONATHAN W also sold $2.63M worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares.

Investors sentiment decreased to 0.86 in Q3 2017. Its down 0.33, from 1.19 in 2017Q2. It turned negative, as 39 investors sold IDXX shares while 196 reduced holdings. 55 funds opened positions while 146 raised stakes. 87.85 million shares or 15.07% more from 76.34 million shares in 2017Q2 were reported. Howland Cap Mgmt Ltd Liability has 193,559 shares for 2.48% of their portfolio. First Personal Financial has 0.02% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 630 shares. Fuller And Thaler Asset Mgmt reported 0.05% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). The Michigan-based Long Road Inv Counsel Lc has invested 1.24% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Pension Service invested 0.08% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Dekabank Deutsche Girozentrale holds 19,090 shares. Fifth Third Bank & Trust owns 21 shares or 0% of their US portfolio. Capital Counsel Limited Company Ny reported 10.2% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Columbus Circle, Connecticut-based fund reported 548,490 shares. The Massachusetts-based Liberty Mutual Grp Incorporated Asset Mgmt has invested 0.03% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Exxonmobil Inv Management Inc Tx has 15,938 shares. British Columbia Invest Mngmt has 92,432 shares for 0.11% of their portfolio. Commerzbank Aktiengesellschaft Fi invested in 0.01% or 3,905 shares. Ruane Cunniff & Goldfarb Inc stated it has 2,919 shares. Fiera Cap stated it has 7,484 shares or 0.01% of all its holdings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts